Cell Line : NCI-H290
Cellosaurus Index : CVCL_A555
Cellosaurus ID : NCI-H290
GDSC1 Name
, GDSC2 Name
: NCI-H290
CCLE Name
: H290_PLEURA
Cancer Type : lung
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| NCI-H290 | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | 5-Fluorouracil | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H290 | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | A-83-01 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | ABT737 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | Afatinib | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| NCI-H290 | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| NCI-H290 | AGK-2 | GDSC2 | 0.0040 | 4.0000 |
|
| NCI-H290 | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| NCI-H290 | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| NCI-H290 | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H290 | Alisertib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Alpelisib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | Ara-G | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| NCI-H290 | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| NCI-H290 | AS605240 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | AT13148 | GDSC2 | 0.0080 | 8.0000 |
|
| NCI-H290 | AT7867 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| NCI-H290 | Axitinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H290 | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | AZD1208 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | AZD1332 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H290 | AZD2014 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H290 | AZD4547 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| NCI-H290 | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| NCI-H290 | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | AZD5438 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H290 | AZD6482 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | AZD7762 | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| NCI-H290 | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | AZD8055 | GDSC1 | 0.0078 | 2.0000 |
|
| NCI-H290 | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| NCI-H290 | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| NCI-H290 | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | BAY-MPS-combo 2 (paclitaxel 1 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| NCI-H290 | BAY-MPS-combo-1 (paclitaxel 5 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| NCI-H290 | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| NCI-H290 | Bexarotene | GDSC1 | 0.0312 | 8.0000 |
|
| NCI-H290 | BI-2536 | GDSC2 | 0.0005 | 0.5000 |
|
| NCI-H290 | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | BIBR-1532 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Bicalutamide | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| NCI-H290 | Bleomycin | GDSC1 | 0.2500 | 64.0000 |
|
| NCI-H290 | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | Bleomycin (50 uM) | GDSC1 | 0.1953 | 50.0000 |
|
| NCI-H290 | BMS-345541 | GDSC1,GDSC2 | 0.0100 | 16.0000 |
|
| NCI-H290 | BMS-536924 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | BMS-754807 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Bortezomib | GDSC2 | 0.0000 | 0.0200 |
|
| NCI-H290 | Bosutinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H290 | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| NCI-H290 | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | BX795 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H290 | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| NCI-H290 | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H290 | CCT-018159 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| NCI-H290 | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| NCI-H290 | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H290 | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| NCI-H290 | CHIR-99021 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | Cisplatin | GDSC1 | 0.0117 | 10.0000 |
|
| NCI-H290 | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H290 | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| NCI-H290 | Crizotinib | GDSC2 | 0.0040 | 8.0000 |
|
| NCI-H290 | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Cytarabine | GDSC1 | 0.0078 | 2.0000 |
|
| NCI-H290 | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Dabrafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H290 | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| NCI-H290 | Dactolisib | GDSC1,GDSC2 | 0.0003 | 0.2500 |
|
| NCI-H290 | Daporinad | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H290 | Dasatinib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H290 | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H290 | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| NCI-H290 | Docetaxel | GDSC1,GDSC2 | 0.0000 | 0.0125 |
|
| NCI-H290 | Doramapimod | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Doxorubicin | GDSC1 | 0.0040 | 5.0000 |
|
| NCI-H290 | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Elesclomol | GDSC1,GDSC2 | 0.0002 | 0.2000 |
|
| NCI-H290 | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| NCI-H290 | Entinostat | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Enzastaurin | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | Epirubicin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| NCI-H290 | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Erlotinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Etoposide | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H290 | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | Fedratinib | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H290 | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| NCI-H290 | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H290 | Foretinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H290 | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H290 | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | Fulvestrant | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| NCI-H290 | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Gefitinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H290 | Gemcitabine | GDSC1,GDSC2 | 0.0002 | 10.0000 |
|
| NCI-H290 | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| NCI-H290 | GSK1059615 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | GSK1070916 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H290 | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 5.0000 |
|
| NCI-H290 | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | GSK269962A | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | GSK343 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H290 | GSK429286A | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H290 | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H290 | HG-5-113-01 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | HG-5-88-01 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H290 | I-BET-762 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | I-BET151 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | IAP_5620 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | IC-87114 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | Idelalisib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | IOX2 | GDSC1,GDSC2 | 0.0004 | 0.5000 |
|
| NCI-H290 | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| NCI-H290 | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Irinotecan | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H290 | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| NCI-H290 | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H290 | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H290 | JQ1 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| NCI-H290 | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H290 | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H290 | KU-55933 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | KU-60019 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | Lapatinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | LCL161 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| NCI-H290 | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H290 | LFM-A13 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H290 | LGK974 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | Linifanib | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H290 | Linsitinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Luminespib | GDSC1,GDSC2 | 0.0003 | 0.2560 |
|
| NCI-H290 | LY2109761 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H290 | Masitinib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H290 | Methotrexate | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| NCI-H290 | MG-132 | GDSC2 | 0.0040 | 4.0000 |
|
| NCI-H290 | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| NCI-H290 | MIM1 | GDSC1 | 0.1562 | 40.0000 |
|
| NCI-H290 | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 |
|
| NCI-H290 | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H290 | MK-1775 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | MK-2206 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H290 | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H290 | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H290 | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | Navitoclax | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H290 | Nilotinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H290 | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H290 | NSC319726 | GDSC1 | 0.0010 | 0.2560 |
|
| NCI-H290 | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H290 | Nutlin-3a | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | NVP-ADW742 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Obatoclax Mesylate | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H290 | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Olaparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| NCI-H290 | OSI-027 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| NCI-H290 | OSI-930 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H290 | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H290 | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Oxaliplatin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | PAC-1 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H290 | Paclitaxel | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H290 | Palbociclib | GDSC1,GDSC2 | 0.0040 | 4.0000 |
|
| NCI-H290 | Panobinostat | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H290 | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H290 | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H290 | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H290 | Pazopanib | GDSC1 | 0.0312 | 8.0000 |
|
| NCI-H290 | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | PD0325901 | GDSC1,GDSC2 | 0.0010 | 2.5000 |
|
| NCI-H290 | PD173074 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H290 | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H290 | Pemetrexed | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H290 | Pevonedistat | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| NCI-H290 | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | PF-4708671 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H290 | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | PHA-793887 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | PI-103 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Pictilisib | GDSC1,GDSC2 | 0.0040 | 4.0000 |
|
| NCI-H290 | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | Piperlongumine | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| NCI-H290 | PLX-4720 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| NCI-H290 | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H290 | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | QL-VIII-58 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | QL-XII-61 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | QS11 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | Quizartinib | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H290 | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | Rapamycin | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H290 | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H290 | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| NCI-H290 | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H290 | Ruxolitinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Sapitinib | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H290 | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H290 | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | SB505124 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| NCI-H290 | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H290 | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H290 | Selumetinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Sepantronium bromide | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Serdemetan | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| NCI-H290 | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H290 | SL0101 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | SN-38 | GDSC1,GDSC2 | 0.0002 | 10.0000 |
|
| NCI-H290 | Sorafenib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Sphingosine Kinase 1 Inhibitor II | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H290 | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| NCI-H290 | SU11274 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | TAK-715 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Tamoxifen | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Tanespimycin | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H290 | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H290 | Taselisib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Telomerase Inhibitor IX | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Temozolomide | GDSC1,GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H290 | Temsirolimus | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| NCI-H290 | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| NCI-H290 | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H290 | Tivozanib | GDSC1 | 0.0005 | 0.1280 |
|
| NCI-H290 | TL-2-105 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | Tozasertib | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H290 | Trametinib | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H290 | Tretinoin | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H290 | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | TW 37 | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H290 | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | Ulixertinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | UNC0638 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| NCI-H290 | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| NCI-H290 | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H290 | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Veliparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H290 | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| NCI-H290 | Vinblastine | GDSC1 | 0.0004 | 0.1000 |
|
| NCI-H290 | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H290 | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Vorinostat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H290 | VX-11e | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| NCI-H290 | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H290 | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | Wnt-C59 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| NCI-H290 | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | XAV939 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H290 | XMD11-85h | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H290 | XMD8-92 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | YK-4-279 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | ZG-10 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H290 | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H290 | ZSTK474 | GDSC1 | 0.0200 | 5.1200 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC